Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension

Journal of the American Society of Nephrology

Volumn 16, Issue 3 SUPPL. 1, 2005, Pages

  Viazzi, Francesca ^a   Leoncini, Giovanna ^a   Parodi, Denise ^a   Ratto, Elena ^a   Vettoretti, Simone ^a   Vaccaro, Valentina ^a   Parodi, Angelica ^a   Falqui, Valeria ^a   Tomolillo, Cinzia ^a   Deferrari, Giacomo ^a   Pontremoli, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CARDIOVASCULAR RISK; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; ECHOCARDIOGRAPHY; ECHOGRAPHY; ESSENTIAL HYPERTENSION; HUMAN; MEDICAL ASSESSMENT; MICROALBUMINURIA; ORGAN INJURY; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; SCREENING; SENSITIVITY ANALYSIS; TARGET ORGAN; ALBUMINURIA; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DOPPLER FLOWMETRY; ECONOMICS; EVALUATION; FEMALE; HEART FUNCTION TEST; HOSPITALIZATION; HYPERTENSION; INCIDENCE; ITALY; MALE; PRACTICE GUIDELINE; PREDICTION AND FORECASTING; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SURVIVAL; URINALYSIS;

ALBUMINURIA; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; EVALUATION STUDIES; FEMALE; HEART FUNCTION TESTS; HUMANS; HYPERTENSION; INCIDENCE; ITALY; MALE; PRACTICE GUIDELINES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; ULTRASONOGRAPHY, DOPPLER; URINALYSIS;

EID: 20844443445     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004110956     Document Type: Conference Paper

References (12)

1. Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for management of arterial hypertension. J Hypertens 21:1011-1053, 2003
2. Zanchetti A, Hansson L, Dahlof B, Elmfeldt D, Kjeldsen S, Kolloch R, Larochelle P, Mclnnes GT, Mallion JM, Ruilope L, Wedel H: Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. J Hypertens 19: 1149-1159, 2001
3. Ogden LG, He J, Lydick E, Whelton PK: Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 35: 539-543, 2000
4. Persson M, Carlberg B, Weinehall L, Nilsson L, Stegmayr B, Lindholm LH: Risk stratification by guidelines compared with risk assessment by risk equations applied to a MONICA sample. J Hypertens 21: 1089-1095, 2003
5. Leoncini G, Sacchi G, Viazzi F, Ravera M, Parodi D, Ratto E, Vettoretti S, Tomolillo C, Deferrari G, Pontremoli R: Microalbuminuria identifies global cardiovascular risk in essential hypertension: An artificial neural network-based approach. J Hypertens 20: 1315-1321, 2002
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC VII report. JAMA 289: 2560-2572, 2003
7. Donnelly R, Rea R: Microalbuminuria: How informative and reliable are individual measurements? J Hypertens 21: 1929-1933, 2003
8. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, Bouter LM, Stehouwer CD: Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: Five-year follow-up of the Hoorn Study. Arterioscler Thromb Vase Biol 19: 617-624, 1999
9. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K: Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 35: 898-903, 2000
10. Hillege HL, Fidler V, Diercks GF, van Gust WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE; Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106: 1777-1782, 2002
11. Nielsen OW, McDonagh TA, Robb SD, Dargie HJ: Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population. J Am Coll Cardiol 41: 113-120, 2003
12. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289: 2363-2369, 2003